News
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
Biophytis announces strategic agreement in Asia and secures $20 million for Phase 3 trial in sarcopenia, including creation of joint venture in Hong Kong and financing over 3 years -
-
-
-
-
-